iBio, Inc. (IBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 700K 1.4M 2.1M Q4 '21: 491K Q1 '22: 84K Q2 '22: 0 Q3 '22: 1.8M Q4 '22: 0 Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 50K Q2 '24: 0 Q3 '24: 0 Q4 '24: 175K Q1 '25: 0 Q2 '25: 200K Q3 '25: 0 Q4 '25: 200K Q1 '26: 100K Q2 '26: 0 Q3 '26: 0 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit Quarterly

0 700K 1.4M 2.1M Q3 '20: 10K Q4 '20: 821K Q1 '21: 303K Q2 '21: 494K Q3 '21: 272K Q4 '21: 304K Q1 '22: 171K Q2 '22: 55K Q3 '22: 1.9M Q4 '22: 46K Q4 '20 Q2 '21 Q4 '21 Q2 '22 Q4 '22

Operating Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q4 '21: -9.4M Q1 '22: -5.2M Q2 '22: -7.2M Q3 '22: -6.8M Q4 '22: -10.5M Q1 '23: -7.6M Q2 '23: -10.6M Q3 '23: -6.2M Q4 '23: -5M Q1 '24: -5.1M Q2 '24: -4.5M Q3 '24: -3.6M Q4 '24: -3.4M Q1 '25: -4.1M Q2 '25: -4.4M Q3 '25: -4.9M Q4 '25: -5.2M Q1 '26: -6M Q2 '26: -9.4M Q3 '26: -8.4M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '22: -8.9M Q2 '22: -11.9M Q3 '22: -12.4M Q4 '22: -17.1M Q1 '23: -18.1M Q2 '23: -33.6M Q3 '23: -7.3M Q4 '23: -6M Q1 '24: -5.7M Q2 '24: -8.2M Q3 '24: -3.2M Q4 '24: -7.8M Q1 '25: -4M Q2 '25: -4.4M Q3 '25: -4.9M Q4 '25: -5.2M Q1 '26: -5.7M Q2 '26: -9M Q3 '26: -7.7M Q4 '26: -10.4M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Cost of Revenue Quarterly

0 200K 400K 600K Q3 '20: 86K Q4 '20: 299K Q1 '21: 107K Q2 '21: 211K Q3 '21: 493K Q4 '21: 187K Q1 '22: 40K Q2 '22: 113K Q3 '22: 48K Q4 '22: 15K Q4 '20 Q2 '21 Q4 '21 Q2 '22 Q4 '22

Operating Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q4 '21: -7.2M Q1 '22: -9.3M Q2 '22: -10.7M Q3 '22: -5.9M Q4 '22: -11.5M Q1 '23: -14M Q2 '23: -7.6M Q3 '23: -3.9M Q4 '23: -5M Q1 '24: -5.3M Q2 '24: -4.7M Q3 '24: -3.7M Q4 '24: -4.9M Q1 '25: -3.7M Q2 '25: -3.9M Q3 '25: -3.1M Q4 '25: -4.6M Q1 '26: -5.7M Q2 '26: -5.2M Q3 '26: -6.1M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow Quarterly

-18M -12M -6M 0 6M 12M 18M Q2 '21: -9.4M Q3 '21: -8.3M Q4 '21: -9.7M Q1 '22: -10.5M Q2 '22: -12.8M Q3 '22: -6.6M Q4 '22: -14.9M Q1 '23: -16.4M Q2 '23: -10.6M Q3 '23: -4.1M Q4 '23: -5.5M Q3 '24: -3.7M Q4 '24: -5.1M Q1 '25: -3.7M Q2 '25: -3.9M Q3 '25: -3.1M Q4 '25: -4.6M Q1 '26: -5.7M Q2 '26: -5.8M Q3 '26: -6.1M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q1 '25 Q4 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q1 '14: 60.6M Q2 '14: 64M Q1 '15: 65.9M Q2 '15: 71M Q3 '21: 215.5M Q1 '22: 8.7M Q2 '22: 8.7M Q3 '22: 8.7M Q1 '23: 8.8M Q2 '23: 490K Q3 '23: 659K Q1 '24: 1.2M Q2 '24: 1.9M Q3 '24: 3.7M Q1 '25: 8.6M Q2 '25: 9.1M Q3 '25: 9.9M Q1 '26: 53M Q2 '26: 99.1M Q3 '26: 119.6M Q2 '14 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q4 '21: -3.01 Q1 '22: -5.36 Q2 '22: -6.69 Q3 '22: -8.07 Q4 '22: -7.15 Q1 '23: -6.80 Q2 '23: -73.86 Q3 '23: -83.51 Q4 '23: -76.46 Q1 '24: -79.21 Q2 '24: -15.20 Q3 '24: -4.98 Q4 '24: -6.50 Q1 '25: -2.16 Q2 '25: 1.78 Q3 '25: 2.14 Q4 '25: -1.74 Q1 '26: -1.39 Q2 '26: -1.00 Q3 '26: -0.57 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.